DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D-Reference-Cited by-同舟云学术

DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D

Published:2022-09 Issue: Volume:26 Page:15-26
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Li Shanglin,Zhao Ruocong^ORCID,Zheng Diwei,Qin Le,Cui Yuanbin,Li Yao,Jiang Zhiwu,Zhong Mengjun,Shi Jingxuan,Li Ming,Wang Xindong,Tang Zhaoyang,Wu Qiting,Long Youguo,Hu Duo,Wang Suna,Yao Yao,Liu Shuang,Yang Li-Hua,Zhang Zhenfeng,Tang Qiannan,Liu Pentao,Li Yangqiu,Li Peng^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference33 articles.

1. Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis;Anagnostou;Lancet Haematol.,2020

2. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

3. CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives;Mohty;Leukemia,2019

4. Genetic modification of cytokine signaling to enhance efficacy of CAR T cell therapy in solid tumors;Ghahri-Saremi;Front. Immunol.,2021

5. Rationally designed transgene-encoded cell-surface polypeptide tag for multiplexed programming of CAR T-cell synthetic outputs;Johnson;Cancer Immunol. Res.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

2. Arming Vδ2 T Cells with Chimeric Antigen Receptors to Combat Cancer;Clinical Cancer Research;2024-05-15

3. Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses;Cell;2024-05

4. Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma;Cancers;2023-11-30

5. Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment;Experimental Hematology & Oncology;2023-01-27